Tech Company Financing Transactions
SeqOnce Funding Round
Mount Wilson Ventures and private investors participated in a $1 million Seed capital raise for SeqOnce. This venture round was announced on 5/14/2018.
Transaction Overview
Company Name
Announced On
5/14/2018
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
Mount Wilson Ventures (Lead Investor) (Michael Giardello)
Proceeds Purpose
The company said it will use the seed funding to support the commercialization of its recently launched Rapid DNA-seq library construction kit for whole-genome NGS. SeqOnce also has library prep kits for Illumina NGS platforms -- called RYNO-seq -- in beta testing.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
2265 E Foothill Blvd.
Pasadena, CA 91107
USA
Pasadena, CA 91107
USA
Phone
Website
Email Address
Overview
SeqOnce Biosciences is a privately held company located in Pasadena, California. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Angermayer
Chief Scientific Officer
Joseph Dunham
Browse more venture capital transactions:
Prev: 5/14/2018: SecureSet Academy venture capital transaction
Next: 5/14/2018: DeepSig venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs